Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. (Q44164570)
Jump to navigation
Jump to search
scientific article published in October 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. |
scientific article published in October 2002 |
Statements
Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer (English)
Kotha Subbaramaiah
Jay Patel
Jaime L Masferrer
Aparna Deora
Clifford Hudis
Howard T Thaler
William J Muller
Baoheng Du
Anthony M C Brown
Andrew J Dannenberg
1 October 2002